FCRL4
Summary: This gene encodes a member of the immunoglobulin receptor superfamily and is one of several Fc receptor-like glycoproteins clustered on the long arm of chromosome 1. The encoded protein has four extracellular C2-type immunoglobulin domains, a transmembrane domain and a cytoplasmic domain that contains three immune-receptor tyrosine-based inhibitory motifs. This protein may play a role in the function of memory B-cells in the epithelia. Aberrations in the chromosomal region encoding this gene are associated with non-Hodgkin lymphoma and multiple myeloma. [provided by RefSeq, Apr 2009].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
Fc receptor like 4 | MIM:605876 | Ensembl:ENSG00000163518 | HGNC:HGNC:18507 | PA142671768 | 1q23.1 |
Gene Categories:
DRUGGABLE GENOMEGO terms in FCRL4
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IEA | GO:0002250 | adaptive immune response |
CC | IEA | GO:0005886 | plasma membrane |
CC | IDA | GO:0009986 | cell surface |
CC | IEA | GO:0016021 | integral component of membrane |
MF | IPI | GO:0005515 | protein binding |
Gene expression in normal tissue: FCRL4
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in FCRL4
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD781 | Sirolimus | 4 |
iGMDRD126 | Tipifarnib | 6 |
iGMDRD579 | PF750 | 3 |
iGMDRD889 | Compound 7d-cis | 4 |
iGMDRD280 | CYTOCHALASIN B | 4 |
iGMDRD679 | Bistramide A | 4 |
iGMDRD6 | AM-580 | 3 |
iGMDRD441 | TW 37 | 1 |
iGMDRD121 | GMX1778 | 3 |
iGMDRD60 | Quinoclamine | 5 |
iGMDRD886 | Compound 1541A | 2 |
iGMDRD322 | FK 866 | 3 |
iGMDRD887 | Compound 23 citrate | 2 |
iGMDRD286 | Nsc 632839 | 4 |
iGMDRD367 | Ro 28-1675 | 3 |
iGMDRD871 | BRD6368 | 5 |
iGMDRD780 | PP-30 | 4 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in FCRL4